Last reviewed · How we verify
Micatex (tribromometacresol)
Micatex (generic name: tribromometacresol) is a tribromometacresol drug. It is currently in unknown development.
Micatex works by disrupting bacterial cell membranes, ultimately leading to cell death.
Tribromometacresol, also known as Micatex, is a small molecule antifungal medication. It belongs to the class of organic compounds known as meta cresols, which contain a benzene ring bearing a methyl group and a hydroxyl group at specific ring positions.
At a glance
| Generic name | tribromometacresol |
|---|---|
| Drug class | tribromometacresol |
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Mechanism of action
Imagine Micatex as a strong detergent that breaks down the protective layer around bacteria, causing them to die. This action helps to eliminate the bacteria that cause infections. By targeting bacterial cell membranes, Micatex can effectively treat infections caused by these microorganisms.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Micatex CI brief — competitive landscape report
- Micatex updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Micatex
What is Micatex?
How does Micatex work?
What is the generic name of Micatex?
What drug class is Micatex in?
What development phase is Micatex in?
Related
- Drug class: All tribromometacresol drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing